Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation.

BACKGROUND: Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 60; no. 3; pp. 399 - 406
Autores principales: Ito, Juliana T., Ramos, Dionei, Lima, Fabiano F., Rodrigues, Fernanda M. M., Gomes, Paulo R., Moreira, Graciane L., Macchione, Mariangela, Toledo, Alessandra C., Ramos, Ercy M. C.
Formato: research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Mar2015
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:BACKGROUND: Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. METHODS: Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 ± 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 ± 8.0 y, 6 males), current smokers (n = 27, 61.5 ± 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 ± 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn’s test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. RESULTS: STT of smokers with COPD (16.5 [11–28] min; median [interquartile range 25–75%]) and current smokers (15.9 [10 –27] min) was longer compared with ex-smokers with COPD (9.7 [6 –12] min) and nonsmokers (8 [6 –16] min) (P < .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P > .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. CONCLUSIONS: One year after smoking cessation, subjects with COPD had improved mucociliary clearance.